Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > It's time to rise now, we need a news soon
View:
Post by sylvain_007 on Jan 17, 2022 4:40pm

It's time to rise now, we need a news soon

With Pfizer and his pill, it's time for THRM to receive their approbation by the fuc.... American FDA.
Comment by hk1966 on Jan 17, 2022 6:34pm
I hope they aren't reading these boards!? 
Comment by stockmonster6 on Jan 18, 2022 8:12am
Yes, as vaccine and therapeutic technology increases and gets better it is only a matter of time before Pfizer creates the vaccine that actually innoculates against Covid 19 and any rapid test will be insignificant. I hope it's this week.  6 months ago, THRM was running out of time. I would like to hear about why we didn't sell units in Europe as was indicated last June.
Comment by Yamaha on Jan 18, 2022 8:59am
Already too late, 18 months no approvals, 100000 EU order never met the conditional requirement of completing a clinical trial in one of the 27 member countries of the EU. CE is not an approval to sell Covid tests it's an accreditation only This is dead money imo Too Late most countries are rolling back the rules fast. Pfizer CEO says pandemic done by spring right or wrong no-one cares about ...more  
Comment by Smokey1958 on Jan 18, 2022 9:34am
1. Not one company got approvals on the first day they said they were going to create a test (18 months). 2. Sorry, but wrong type of virus! No company is going to create a single vaccine to combat this. If this had been the case influenza would be history. On the other hand it is becoming apparent that any company that can create a test that can distinguish covid from the flu from a cold may ...more  
Comment by Yamaha on Jan 18, 2022 9:47am
Albert Bourla, the CEO of Pfizer, said in an interview published late Sunday that he believes there will be a "return to normal life" sometime in the spring after over two years of dealing with the COVID-19 pandemic, Le Figaro French News
Comment by Smokey1958 on Jan 18, 2022 10:13am
Best to copy the whole quote. Meanwhile, Pfizer chief executive Albert Bourla predicted that “we will soon be able to resume a normal life,” given pandemic mitigation measures including tests and vaccines. But he also said that doesn’t mean an end to the coronavirus. “We’ve had so many surprises since the start of the pandemic,” he said in an interview published Sunday in the French newspaper ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities